Literature DB >> 28743981

NAFLD: Type 2 immunity drives progression of NAFLD.

Katrina Ray.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28743981     DOI： 10.1038/nrgastro.2017.105

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.

Authors:  Kevin M Hart; Thomas Fabre; Joshua C Sciurba; Richard L Gieseck; Lee A Borthwick; Kevin M Vannella; Thomas H Acciani; Rafael de Queiroz Prado; Robert W Thompson; Sandra White; Genevieve Soucy; Marc Bilodeau; Thirumalai R Ramalingam; Joseph R Arron; Naglaa H Shoukry; Thomas A Wynn
Journal:  Sci Transl Med       Date:  2017-06-28       Impact factor: 17.956
  1 in total
  1 in total

1.  Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer.

Authors:  Lingyi Sun; Yongkang Gai; Zhonghan Li; Huiqiang Li; Jianchun Li; John Muschler; Rui Kang; Daolin Tang; Dexing Zeng
Journal:  Mol Imaging Biol       Date:  2022-02-28       Impact factor: 3.484
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.